4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-23-000197
SVP Corporate Strategy-Develop sold 56 shares at $102.32 ($5,730)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dolan Matthew Vincent SVP Corporate Strategy-Develop | 2023-09-01 | Sale | −56 | $102.32 | $5,730 | 33,569 | D |
| Open-market sales · 56 sh · avg $102.32 · $5,730 | |||||||
Loading xslF345X05/edgardoc.xml…